|
US3138588A
(en)
|
1962-08-24 |
1964-06-23 |
American Home Prod |
17-ketals of estrone and derivatives thereof
|
|
US3433785A
(en)
|
1966-07-11 |
1969-03-18 |
Sterling Drug Inc |
15,16-disubstituted aromatic steroids,intermediates and processes
|
|
US4826831A
(en)
|
1983-08-05 |
1989-05-02 |
Pre Jay Holdings Limited |
Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
|
|
CA1306950C
(en)
|
1987-04-10 |
1992-09-01 |
Alec D. Keith |
Buccal administration of estrogens
|
|
US5073374A
(en)
*
|
1988-11-30 |
1991-12-17 |
Schering Corporation |
Fast dissolving buccal tablet
|
|
CA2011063C
(en)
|
1989-02-28 |
1999-07-06 |
Calum B. Macfarlane |
Nicardipine pharmaceutical composition for parenteral administration
|
|
US5340585A
(en)
|
1991-04-12 |
1994-08-23 |
University Of Southern California |
Method and formulations for use in treating benign gynecological disorders
|
|
US5340586A
(en)
|
1991-04-12 |
1994-08-23 |
University Of Southern California |
Methods and formulations for use in treating oophorectomized women
|
|
US5895783A
(en)
|
1993-07-16 |
1999-04-20 |
Schering Aktiengesellschaft |
Treatment of preeclampsia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor
|
|
JPH07101977A
(ja)
|
1993-10-05 |
1995-04-18 |
Kureha Chem Ind Co Ltd |
ホルモン作用を軽減した新規なエストラジオール誘導体及びその増殖因子阻害剤
|
|
DE4344405C2
(de)
|
1993-12-24 |
1995-12-07 |
Marika Dr Med Ehrlich |
Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption
|
|
WO1997004752A1
(en)
|
1995-07-26 |
1997-02-13 |
Duramed Pharmaceuticals, Inc. |
Pharmaceutical compositions of conjugated estrogens and methods for their use
|
|
FR2772272B1
(fr)
|
1997-12-16 |
2000-01-14 |
Rhone Poulenc Rorer Sa |
Compositions pharmaceutiques a base de dalfopristine et de quinupristine et leur preparation
|
|
HUP0100469A2
(hu)
|
1997-12-19 |
2001-08-28 |
Smithkline Beecham Corporation |
Eljárás harapással diszpergálható tabletták előállítására
|
|
US7815937B2
(en)
|
1998-10-27 |
2010-10-19 |
Biovail Laboratories International Srl |
Quick dissolve compositions and tablets based thereon
|
|
US6117446A
(en)
|
1999-01-26 |
2000-09-12 |
Place; Virgil A. |
Drug dosage unit for buccal administration of steroidal active agents
|
|
US6180682B1
(en)
*
|
1999-01-26 |
2001-01-30 |
Virgil A. Place |
Buccal drug delivery system for use in male contraception
|
|
TW548277B
(en)
|
1999-07-16 |
2003-08-21 |
Akzo Nobel Nv |
Orally active androgens
|
|
WO2001040255A2
(en)
|
1999-12-02 |
2001-06-07 |
Akzo Nobel N.V. |
14,15-beta-methylene substituted androgens
|
|
US20020132801A1
(en)
|
2001-01-11 |
2002-09-19 |
Schering Aktiengesellschaft |
Drospirenone for hormone replacement therapy
|
|
FR2809619B1
(fr)
|
2000-06-06 |
2004-09-24 |
Pharmatop |
Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
|
|
EP1216713A1
(en)
|
2000-12-20 |
2002-06-26 |
Schering Aktiengesellschaft |
Compositions of estrogen-cyclodextrin complexes
|
|
EP1260225A1
(en)
|
2001-05-18 |
2002-11-27 |
Pantarhei Bioscience B.V. |
A pharmaceutical composition for use in hormone replacement therapy
|
|
ES2278924T3
(es)
*
|
2001-05-18 |
2007-08-16 |
Pantarhei Bioscience B.V. |
Composicion farmaceutica para el uso en terapia de sustitucion hormonal.
|
|
TR200400183T4
(tr)
*
|
2001-05-23 |
2004-02-23 |
Pantarhei Bioscience B.V. |
Hormonal kontrasepsiyon için vasıta ve metot
|
|
PT1390042E
(pt)
|
2001-05-23 |
2008-03-10 |
Pantarhei Bioscience Bv |
Sistema de administração de um medicamento que compreende estrogénio tetrahidroxilado destinado à contracepção hormonal
|
|
EP1390041B1
(en)
|
2001-05-23 |
2009-11-25 |
Pantarhei Bioscience B.V. |
Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
|
|
US20020193356A1
(en)
|
2001-05-23 |
2002-12-19 |
Van Beek Agatha Antonia Magdalena |
Means and method for hormonal contraception
|
|
WO2003018026A1
(en)
|
2001-08-31 |
2003-03-06 |
Pantarhei Bioscience B.V. |
Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
|
|
US8026228B2
(en)
*
|
2001-11-15 |
2011-09-27 |
Pantarhei Bioscience B.V. |
Estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
|
|
US6723348B2
(en)
|
2001-11-16 |
2004-04-20 |
Ethypharm |
Orodispersible tablets containing fexofenadine
|
|
HU227198B1
(en)
|
2001-11-27 |
2010-10-28 |
Richter Gedeon Nyrt |
Pharmaceutical composition for emergency contraception containing levonorgestrel
|
|
AU2002343249B2
(en)
|
2002-02-21 |
2009-02-05 |
Bayer Schering Pharma Aktiengesellschaft |
Pharmaceutical compositions comprising one or more steroids one or more tetrahydrofolate components and vitamin B12
|
|
US20050147670A1
(en)
|
2002-05-29 |
2005-07-07 |
Impax Laboratories Inc. |
Oral disintegrating dosage forms
|
|
AU2003274941A1
(en)
|
2002-06-11 |
2003-12-22 |
Pantarhei Bioscience B.V. |
A method of treating human skin and a skin care composition for use in such a method
|
|
WO2003103684A1
(en)
|
2002-06-11 |
2003-12-18 |
Pantarhei Bioscience B.V. |
Method of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein
|
|
AU2003253506A1
(en)
|
2002-07-12 |
2004-02-02 |
Pantarhei Biosciences B.V. |
Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy
|
|
ATE345804T1
(de)
|
2002-08-28 |
2006-12-15 |
Robert Casper |
Estrogenersatztherapie
|
|
DE60318092T2
(de)
|
2002-10-23 |
2008-11-27 |
Pantarhei Bioscience B.V. |
Pharmazeutische zusammensetzung enthaltend estetrolderivate und anwendung in der krebsbehandlung
|
|
DE60330888D1
(de)
|
2002-11-05 |
2010-02-25 |
Bayer Schering Pharma Ag |
Verwendung von drospirenon zur behandlung von hypertension
|
|
ES2346053T3
(es)
|
2002-11-08 |
2010-10-08 |
Pantarhei Bioscience B.V. |
Sintesis de esterol a traves de esteroides derivados de estrona.
|
|
DK1624878T3
(da)
|
2003-05-22 |
2007-01-08 |
Pantarhei Bioscience Bv |
Anvendelse af præparater som omfatter en östrogen komponent til behandling og forebyggelse af muskel-skelet-smerte
|
|
WO2005030175A1
(en)
|
2003-09-29 |
2005-04-07 |
Novo Nordisk Femcare Ag |
Hrt formulations
|
|
WO2005030176A1
(en)
|
2003-09-29 |
2005-04-07 |
Novo Nordisk Femcare Ag |
Improved stability of progestogen formulations
|
|
JP3841804B2
(ja)
|
2003-10-15 |
2006-11-08 |
富士化学工業株式会社 |
口腔内速崩壊性錠剤用の組成物
|
|
EP1535618A1
(en)
|
2003-11-26 |
2005-06-01 |
Schering Aktiengesellschaft |
Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions
|
|
MY151322A
(en)
|
2004-04-30 |
2014-05-15 |
Bayer Ip Gmbh |
Management of breakthrough bleeding in extended hormonal contraceptive regimens
|
|
GB0410616D0
(en)
|
2004-05-13 |
2004-06-16 |
Unilever Plc |
Antiperspirant or deodorant compositions
|
|
DE102004026670A1
(de)
|
2004-05-28 |
2005-12-15 |
Grünenthal GmbH |
Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
|
|
PT1755562E
(pt)
|
2004-05-28 |
2013-12-26 |
Richter Gedeon Nyrt |
Contraceptivo contendo ácido fólico
|
|
EA013211B1
(ru)
|
2004-07-01 |
2010-04-30 |
Лек Фармасьютиклз Д.Д. |
Быстрораспадающаяся диспергирующаяся во рту лекарственная форма и способ ее приготовления
|
|
UA89964C2
(ru)
|
2004-09-08 |
2010-03-25 |
Н.В. Органон |
15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
|
|
EP1845950A2
(en)
|
2005-02-03 |
2007-10-24 |
Nycomed Pharma AS |
Fast wet-massing method for the preparation of calcium-containing compositions
|
|
IS7724A
(is)
|
2005-03-02 |
2006-09-03 |
Actavis Group |
Samsetning á töflum með hraða sundrun sem innihalda þungt magnesíum karbónat
|
|
UY29527A1
(es)
|
2005-05-13 |
2006-12-29 |
Schering Ag |
Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato.
|
|
ES2388297T3
(es)
|
2005-05-26 |
2012-10-11 |
Abbott Products Gmbh |
Inhibidores de 17-HSD1 y STS
|
|
US20070048369A1
(en)
*
|
2005-08-26 |
2007-03-01 |
National Starch And Chemical Investment Holding Corporation |
Mucosal delivery tablet
|
|
DE602007009358D1
(de)
*
|
2006-01-09 |
2010-11-04 |
Pantarhei Bioscience Bv |
Verfahren zur behandlung einer akuten gefässerkrankung
|
|
US20090221540A1
(en)
|
2006-01-09 |
2009-09-03 |
Pantarhei Bioscience B.V. |
Method of Treating An Acute Vascular Disorder
|
|
MX2008011074A
(es)
|
2006-03-02 |
2008-09-10 |
Warner Chilcott Co Inc |
Metodo anticonceptivo oral multifasico de ciclo prolongado.
|
|
MX2008014941A
(es)
*
|
2006-06-08 |
2008-12-10 |
Warner Chilcott Co Inc |
Metodos para administrar formas de dosificacion solida de etinil estradiol y profarmacos del mismo con biodisponibilidad mejorada.
|
|
US20070286819A1
(en)
*
|
2006-06-08 |
2007-12-13 |
Warner Chilcott Company, Inc. |
Methods to administer ethinyl estradiol and prodrugs thereof with improved bioavailability
|
|
US20080113953A1
(en)
|
2006-06-08 |
2008-05-15 |
Warner Chilcott Company, Inc. |
Methods to administer solid dosage forms of ethinyl estradiol and prodrugs thereof with improved bioavailability
|
|
MX2009000256A
(es)
|
2006-07-06 |
2009-02-18 |
Bayer Schering Pharma Ag |
Preparaciones farmaceuticas para la anticoncepcion y para prevenir el riesgo de malformaciones congenitas.
|
|
CN101489563A
(zh)
|
2006-07-06 |
2009-07-22 |
拜耳先灵医药股份有限公司 |
用于避孕和预防先天性畸形风险的药物制剂
|
|
WO2008067387A2
(en)
|
2006-11-29 |
2008-06-05 |
Wyeth |
Estrogen/ serm and estrogen/ progestin bi-layer tablets
|
|
WO2008079245A2
(en)
|
2006-12-20 |
2008-07-03 |
Duramed Pharmaceuticals, Inc. |
Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
|
|
US8236785B2
(en)
|
2007-01-08 |
2012-08-07 |
Pantarhei Bioscience B.V. |
Method of treating or preventing infertility in a female mammal and pharmaceutical kit for use in such method
|
|
BRPI0806543A2
(pt)
|
2007-01-12 |
2014-04-22 |
Wyeth Corp |
Composições de comprimido em comprimido
|
|
EP1972618A1
(en)
|
2007-03-20 |
2008-09-24 |
Nabriva Therapeutics AG |
Pleuromutilin derivatives for the treatment of diseases mediated by microbes
|
|
ATE537833T1
(de)
|
2007-06-21 |
2012-01-15 |
Pantarhei Bioscience Bv |
Behandlung des mekoniumaspirationssyndroms mit östrogenen
|
|
US8518923B2
(en)
|
2007-07-19 |
2013-08-27 |
Pantarhei Bioscience B.V. |
Treatment or prevention of hypertensive disorders of pregnancy or fetal growth retardation
|
|
FR2920311B1
(fr)
|
2007-08-31 |
2010-06-18 |
Galenix Innovations |
Composition solide, orodispersible et/ou dispersible, sans excipient a effet notoire et son procede de preparation
|
|
JP5399749B2
(ja)
|
2008-03-27 |
2014-01-29 |
沢井製薬株式会社 |
プロトンポンプ阻害剤を含有する被覆微粒子
|
|
WO2010033832A2
(en)
|
2008-09-19 |
2010-03-25 |
Evestra, Inc. |
Estriol formulations
|
|
CN101780073B
(zh)
|
2009-01-21 |
2013-07-03 |
重庆圣华曦药业股份有限公司 |
非布司他分散片药物及其制备方法
|
|
JP5753661B2
(ja)
|
2009-01-26 |
2015-07-22 |
信越化学工業株式会社 |
低置換度ヒドロキシプロピルセルロース水分散液を用いた湿式造粒打錠法
|
|
DE102009007771B4
(de)
|
2009-02-05 |
2012-02-16 |
Bayer Schering Pharma Aktiengesellschaft |
Bukkales Applikationssystem, 17α-Estradiol enthaltend
|
|
WO2010109019A1
(en)
|
2009-03-26 |
2010-09-30 |
Royal College Of Surgeons In Ireland |
Orodispersible tablets
|
|
ITMI20091109A1
(it)
|
2009-06-23 |
2010-12-24 |
Wyeth Corp |
Forma polimorfa d di bazedoxifene acetato e metodi per la sua preparazione
|
|
BRPI1011815A2
(pt)
|
2009-06-23 |
2016-03-29 |
Bayer Pharma AG |
"composição farmacêutica para a contracepção de emergência"
|
|
CN102058604A
(zh)
|
2009-11-17 |
2011-05-18 |
北京万全阳光医学技术有限公司 |
一种含有地诺孕素和戊酸雌二醇的药物组合物及其制备方法
|
|
MX356702B
(es)
|
2010-04-15 |
2018-06-11 |
Bayer Ip Gmbh |
Formas de dosificación sólidas orales con dosis muy bajas para la hrt.
|
|
EP2399904A1
(en)
|
2010-05-26 |
2011-12-28 |
Nabriva Therapeutics AG |
Process for the preparation of pleuromutilins
|
|
AR081670A1
(es)
|
2010-06-29 |
2012-10-10 |
Leon Farma Sa Lab |
Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
|
|
US10849857B2
(en)
|
2010-07-28 |
2020-12-01 |
Laboratorios Leon Farma Sa |
Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
|
|
US9603860B2
(en)
|
2010-07-28 |
2017-03-28 |
Laboratorios Leon Farma Sa |
Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
|
|
WO2012055840A1
(en)
|
2010-10-28 |
2012-05-03 |
Bayer Pharma Aktiengesellschaft |
Composition and preparation for treatment of dysmenorrhea and menstrual pain and use of a hormonal agent and a zinc salt for treatment of menstrual disorders
|
|
CN108969490A
(zh)
|
2010-12-02 |
2018-12-11 |
艾戴尔医药公司 |
快速分散颗粒、口腔崩解片以及方法
|
|
JP2012240917A
(ja)
|
2011-05-16 |
2012-12-10 |
Zensei Yakuhin Kogyo Kk |
製剤化用微粒子とそれを含む製剤
|
|
AU2012264602B2
(en)
|
2011-06-01 |
2017-03-09 |
Estetra Srl |
Process for the production of estetrol intermediates
|
|
WO2012164095A1
(en)
|
2011-06-01 |
2012-12-06 |
Estetra S.A. |
Process for the production of estetrol intermediates
|
|
EP2383279A1
(en)
|
2011-07-19 |
2011-11-02 |
Pantarhei Bioscience B.V. |
Process for the preparation of estetrol
|
|
WO2013012326A1
(en)
|
2011-07-19 |
2013-01-24 |
Pantarhei Bioscience B.V. |
Tablet containing dehydroepiandrosterone (dhea)
|
|
EP2741824B1
(en)
|
2011-08-11 |
2017-05-03 |
Estetra S.P.R.L. |
Use of estetrol as emergency contraceptive
|
|
MX345674B
(es)
|
2011-09-16 |
2017-02-10 |
Ferring Bv |
Composicion farmaceutica de disolucion rapida.
|
|
AU2012320423C1
(en)
|
2011-10-07 |
2018-01-25 |
Estetra Srl |
Process for the production of estetrol
|
|
EP2790688B1
(en)
|
2011-12-13 |
2019-11-20 |
Arstat, Inc. |
A multiphasic contraceptive regimen for an oral formulation of progestin and estrogen
|
|
US9808470B2
(en)
|
2012-04-19 |
2017-11-07 |
Universite De Liege |
Estrogenic components for use in the treatment of neurological disorders
|
|
EP2653163A1
(en)
|
2012-04-19 |
2013-10-23 |
Université de Liège |
Estrogenic components for use in the treatment of neurological disorders
|
|
US9238265B2
(en)
|
2012-09-27 |
2016-01-19 |
General Electric Company |
Backstrike protection during machining of cooling features
|
|
WO2014159377A1
(en)
*
|
2013-03-14 |
2014-10-02 |
Teva Women's Health, Inc. |
Compositions containing tanaproget and natural estrogens
|
|
JP6126456B2
(ja)
|
2013-05-17 |
2017-05-10 |
東和薬品株式会社 |
打錠用顆粒とその製造方法、その打錠用顆粒を用いた口腔内崩壊錠
|
|
AU2014268779A1
(en)
|
2013-05-21 |
2016-01-21 |
Predictive Therapeutics, LLC |
Therapeutic and method of use
|
|
WO2015040051A1
(en)
|
2013-09-18 |
2015-03-26 |
Crystal Pharma, S.A.U. |
Process for the preparation of estetrol
|
|
US12274276B2
(en)
|
2013-10-03 |
2025-04-15 |
Altria Client Services Llc |
Dissolvable-chewable tablet
|
|
WO2015086643A1
(en)
*
|
2013-12-12 |
2015-06-18 |
Donesta Bioscience B.V. |
Orally disintegrating solid dosage unit containing an estetrol component
|
|
WO2016053946A1
(en)
|
2014-09-29 |
2016-04-07 |
The Regents Of The University Of California |
Compositions and methods for maintaining cognitive function
|
|
WO2016187269A1
(en)
|
2015-05-18 |
2016-11-24 |
Agile Therapeutics, Inc. |
Contraceptive compositions and methods for improved efficacy and modulation of side effects
|
|
UA123099C2
(uk)
|
2015-06-18 |
2021-02-17 |
Естетра Спрл |
Диспергована в порожнині рота одиниця дозування, яка містить естетрольний компонент
|
|
MD3310346T2
(ro)
|
2015-06-18 |
2021-06-30 |
Estetra Sprl |
Comprimată orodispersabilă ce conține estetrol
|
|
HRP20210668T1
(hr)
|
2015-06-18 |
2021-05-28 |
Estetra Sprl |
Orodisperzibilna tableta koja sadrži estetrol
|
|
US20160367567A1
(en)
|
2015-06-18 |
2016-12-22 |
Mithra Pharmaceuticals S.A. |
Orodispersible dosage unit containing an estetrol component
|
|
HUE065350T2
(hu)
|
2015-06-23 |
2024-05-28 |
Laboratorios Leon Farma Sa |
Drospirenonalapú fogamzásgátló túlsúllyal érintett nõi beteg számára
|
|
JP2018533542A
(ja)
|
2016-10-28 |
2018-11-15 |
エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ |
月経困難症および月経痛の管理のための方法
|
|
US20200046729A1
(en)
|
2016-08-05 |
2020-02-13 |
Estetra Sprl |
Methods using combined oral contraceptive compositions with reduced cardiovascular effects
|
|
CA3178291A1
(en)
|
2016-08-05 |
2018-04-12 |
Estetra Srl |
Method for the management of dysmenorrhea and menstrual pain
|
|
CA3178181A1
(en)
|
2018-02-07 |
2019-08-15 |
Estetra Srl |
Contraceptive composition with reduced cardiovascular effects
|
|
TWI801561B
(zh)
|
2018-04-19 |
2023-05-11 |
比利時商依思特拉私人有限責任公司 |
化合物及其用於緩解絕經相關症狀的用途
|
|
JOP20200260A1
(ar)
|
2018-04-19 |
2019-10-19 |
Estetra Sprl |
مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
|
|
TWI893101B
(zh)
|
2020-04-16 |
2025-08-11 |
比利時商埃斯特拉有限責任公司 |
具有降低之副作用之避孕組成物
|